These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 15641869)
21. Association between haemorrhages and treatment with selective and non-selective serotonergic antidepressants: Possible implications of quantitative signal detection. Gahr M; Zeiss R; Lang D; Connemann BJ; Hiemke C; Muche R; Freudenmann RW; Schönfeldt-Lecuona C Psychiatry Res; 2015 Sep; 229(1-2):257-63. PubMed ID: 26208982 [TBL] [Abstract][Full Text] [Related]
22. Risk of cerebrovascular events associated with antidepressant use in patients with depression: a population-based, nested case-control study. Chen Y; Guo JJ; Li H; Wulsin L; Patel NC Ann Pharmacother; 2008 Feb; 42(2):177-84. PubMed ID: 18212255 [TBL] [Abstract][Full Text] [Related]
23. Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients. de Abajo FJ Drugs Aging; 2011 May; 28(5):345-67. PubMed ID: 21542658 [TBL] [Abstract][Full Text] [Related]
24. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn]. Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456 [TBL] [Abstract][Full Text] [Related]
25. Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something? Serebruany VL Am J Med; 2006 Feb; 119(2):113-6. PubMed ID: 16443409 [TBL] [Abstract][Full Text] [Related]
26. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776 [TBL] [Abstract][Full Text] [Related]
27. Impact of an Interaction Between Clopidogrel and Selective Serotonin Reuptake Inhibitors. Bykov K; Schneeweiss S; Donneyong MM; Dong YH; Choudhry NK; Gagne JJ Am J Cardiol; 2017 Feb; 119(4):651-657. PubMed ID: 27939386 [TBL] [Abstract][Full Text] [Related]
28. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis. Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090 [TBL] [Abstract][Full Text] [Related]
29. Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly. Draper B; Berman K Drugs Aging; 2008; 25(6):501-19. PubMed ID: 18540689 [TBL] [Abstract][Full Text] [Related]
30. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Vaswani M; Linda FK; Ramesh S Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):85-102. PubMed ID: 12551730 [TBL] [Abstract][Full Text] [Related]
32. "Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review. Damsa C; Bumb A; Bianchi-Demicheli F; Vidailhet P; Sterck R; Andreoli A; Beyenburg S J Clin Psychiatry; 2004 Aug; 65(8):1064-8. PubMed ID: 15323590 [TBL] [Abstract][Full Text] [Related]
33. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults. Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028 [TBL] [Abstract][Full Text] [Related]
34. Antidepressants for people with epilepsy and depression. Maguire MJ; Weston J; Singh J; Marson AG Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360 [TBL] [Abstract][Full Text] [Related]
35. The association of selective serotonin reuptake inhibitors use and stroke in geriatric population. Hung CC; Lin CH; Lan TH; Chan CH Am J Geriatr Psychiatry; 2013 Aug; 21(8):811-5. PubMed ID: 23567390 [TBL] [Abstract][Full Text] [Related]
36. Selective serotonin re-uptake inhibitors and the risk of bleeding. Weinrieb RM; Auriacombe M; Lynch KG; Lewis JD Expert Opin Drug Saf; 2005 Mar; 4(2):337-44. PubMed ID: 15794724 [TBL] [Abstract][Full Text] [Related]
37. A critical review of selective serotonin reuptake inhibitor-associated bleeding: balancing the risk of treating hepatitis C-infected patients. Weinrieb RM; Auriacombe M; Lynch KG; Chang KM; Lewis JD J Clin Psychiatry; 2003 Dec; 64(12):1502-10. PubMed ID: 14728113 [TBL] [Abstract][Full Text] [Related]
38. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability. Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011 [TBL] [Abstract][Full Text] [Related]
40. Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression. Mourilhe P; Stokes PE Drug Saf; 1998 Jan; 18(1):57-82. PubMed ID: 9466088 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]